Brief: Iovance Biotherapeutics Announces Clearance Of Investigational New Drug (Ind) Application For Il-12 Tethered Til Therapy IOV-5001
01/06/2026 12:43
BRIEF-Iovance Biotherapeutics Announces Clearance Of Investigational New Drug (Ind) Application For Il-12 Tethered Til Therapy IOV-5001 June 1 (Reuters) - Iovance Biotherapeutics Inc IOVA.O:
IOVANCE BIOTHERAPEUTICS ANNOUNCES CLEARANCE OF INVESTIGATIONAL NEW DRUG (IND) APPLICATION FOR IL-12 TETHERED TIL THERAPY IOV-5001
Source text: ID:nGNX6RWp3Y
Further company coverage: IOVA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Iovance Biotherapeutics
See all newsBrief: Iovance Biotherapeutics Reports Inducement Grants
US RESEARCH ROUNDUP-BlackRock, Evercore, Goldman Sachs
Brief: Iovance Biotherapeutics Appoints Noah Berkowitz, M.D., Ph.D., As Chief Medical Officer
Iovance hits two-year high after raising annual revenue forecast
U.S. RESEARCH ROUNDUP- Berkshire Hathaway, Exxon Mobil, Honeywell Technologies